Cargando…
A biomimetic chip to assess subcutaneous bioavailability of monoclonal antibodies in humans
Subcutaneous (subQ) injection is a common route for delivering biotherapeutics, wherein pharmacokinetics is largely influenced by drug transport in a complex subQ tissue microenvironment. The selection of good drug candidates with beneficial pharmacokinetics for subQ injections is currently limited...
Autores principales: | Chandran Suja, Vineeth, Qi, Qin M, Halloran, Kevin, Zhang, Jifeng, Shaha, Suyog, Prakash, Supriya, Kumbhojkar, Ninad, Deslandes, Antoine, Huille, Sylvain, Gokarn, Yatin R, Mitragotri, Samir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612570/ https://www.ncbi.nlm.nih.gov/pubmed/37901442 http://dx.doi.org/10.1093/pnasnexus/pgad317 |
Ejemplares similares
-
A backpack-based myeloid cell therapy for multiple sclerosis
por: Kapate, Neha, et al.
Publicado: (2023) -
Formulation‐based approaches for dermal delivery of vaccines and therapeutic nucleic acids: Recent advances and future perspectives
por: Sallam, Marwa A., et al.
Publicado: (2021) -
Alzheimer's and Parkinson's disease therapies in the clinic
por: Chopade, Puja, et al.
Publicado: (2022) -
Influence of physiochemical properties on the subcutaneous absorption and bioavailability of monoclonal antibodies
por: Datta-Mannan, Amita, et al.
Publicado: (2020) -
Treatment of psoriasis with NFKBIZ siRNA using topical ionic liquid formulations
por: Mandal, Abhirup, et al.
Publicado: (2020)